Literature DB >> 2529820

[LH episodes in high performance sports].

A S Wolf1, R Benz, G Keckstein, K Sterzik.   

Abstract

For the elucidation of hypothalamic factors, which predominantly cause exercise-amenorrhea 10 untrained and 6 trained volunteers were experimentally tested during 6 hours of rest (R) and 2 hours long distance run (E). The exercise exerted several physical and metabolic demands, leading to increment of LH pulse frequently mainly in trained women (interpulse-interval IPI, R: 104 +/- 50, E: 78.8 +/- 33), due to unaltered beta-endorphin (R: 6.4 +/- 2, E: 6.5 +/- 1.5) and augmented norepinephrine (R: 462 +/- 275, E: 1267 +/- 773 pg/ml). In untrained subjects LH pulses decreased in frequency, as a consequence of increased beta-E and NE (R: 6 +/- 3, E: 12.2 +/- 7.4 pg/ml) (R: 432 +/- 208, E: 947 +/- 473).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529820     DOI: 10.1007/bf02417672

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  4 in total

1.  Altered neuroendocrine regulation of gonadotropin secretion in women distance runners.

Authors:  J D Veldhuis; W S Evans; L M Demers; M O Thorner; D Wakat; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

2.  Defects in pulsatile LH release in normally menstruating runners.

Authors:  D C Cumming; M M Vickovic; S R Wall; M R Fluker
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

3.  Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women.

Authors:  D B Carr; B A Bullen; G S Skrinar; M A Arnold; M Rosenblatt; I Z Beitins; J B Martin; J W McArthur
Journal:  N Engl J Med       Date:  1981-09-03       Impact factor: 91.245

4.  The role of beta-endorphins and catechol estrogens on the hypothalamic-pituitary axis in female athletes.

Authors:  J B Russell; D E Mitchell; P I Musey; D C Collins
Journal:  Fertil Steril       Date:  1984-11       Impact factor: 7.329

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.